| 查看: 322 | 回复: 0 | |||
lubenle至尊木虫 (职业作家)
|
[交流]
FDA认为无证据表明没有心脏病或中风史的人服用阿斯匹灵有预防心脏病发作或中风作用
|
|
Use of Aspirin for Primary Prevention of Heart Attack and Stroke http://www.fda.gov/Drugs/ResourcesForYou/Consumers/ucm390574.htm FDA认为无证据表明没有心脏病或中风史的人服用阿斯匹灵有预防心脏病发作或中风作用， 但对于有心脏病或中风史的人服用阿斯匹灵有预防再次发作的作用！ [05/02/2014] Cardiovascular disease, including heart disease and stroke, affects tens of millions of people in the United States. Consumers and patients who do not suffer from cardiovascular disease sometimes consider taking aspirin to reduce the possibility of having a heart attack or stroke. Reducing the possibility of having a first heart attack or stroke is called primary prevention. The FDA has reviewed the available data and does not believe the evidence supports the general use of aspirin for primary prevention of a heart attack or stroke. In fact, there are serious risks associated with the use of aspirin, including increased risk of bleeding in the stomach and brain, in situations where the benefit of aspirin for primary prevention has not been established. The available evidence supports the use of aspirin for preventing another heart attack or stroke in patients who have cardiovascular disease or who have already had a heart attack or stroke. Reducing the risk of additional heart attacks or strokes is known as secondary prevention. In patients who have had a cardiovascular event, the known benefits of aspirin for secondary prevention outweigh the risk of bleeding. |
回复此楼» 猜你喜欢
有人知道今年北京自然科学基金什么时候会评吗？
已经有14人回复
-
Ai科研绘图求助
已经有4人回复
-
循环系统论文润色/翻译怎么收费?
已经有158人回复
-
护理337求调剂
已经有0人回复
-
北京市自然科学基金-海淀原始创新基金
已经有0人回复
-
「中华医学会成立110周年专栏」重新思考肿瘤
已经有47人回复
-
慢病毒难以转染CAF如何改进实验方案
已经有0人回复
30